ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129,602 | -29.1% | 1,089 | +6.1% | 0.00% | – |
| Q2 2023 | $182,823 | -7.9% | 1,026 | -14.7% | 0.00% | – |
| Q1 2023 | $198,447 | +57.5% | 1,203 | +50.4% | 0.00% | – |
| Q4 2022 | $125,984 | -99.9% | 800 | -41.3% | 0.00% | – |
| Q3 2022 | $205,418,000 | -51.7% | 1,364 | -47.3% | 0.00% | -100.0% |
| Q2 2022 | $425,113,000 | -77.6% | 2,586 | -69.6% | 0.00% | -66.7% |
| Q1 2022 | $1,896,670,000 | +2.7% | 8,519 | +9.5% | 0.00% | 0.0% |
| Q4 2021 | $1,846,031,000 | +184.7% | 7,778 | +180.0% | 0.00% | +200.0% |
| Q3 2021 | $648,330,000 | -67.7% | 2,778 | -71.5% | 0.00% | -66.7% |
| Q2 2021 | $2,009,431,000 | -71.6% | 9,764 | -71.7% | 0.00% | -70.0% |
| Q1 2021 | $7,082,955,000 | +431.7% | 34,477 | +455.1% | 0.01% | +400.0% |
| Q4 2020 | $1,332,197,000 | +42.8% | 6,211 | +21.7% | 0.00% | +100.0% |
| Q3 2020 | $932,807,000 | -1.8% | 5,104 | -1.0% | 0.00% | -50.0% |
| Q2 2020 | $950,302,000 | +5.7% | 5,156 | +15.8% | 0.00% | 0.0% |
| Q1 2020 | $898,684,000 | +159.6% | 4,454 | +140.8% | 0.00% | +100.0% |
| Q4 2019 | $346,172,000 | -83.7% | 1,850 | -86.1% | 0.00% | -75.0% |
| Q3 2019 | $2,128,266,000 | -42.6% | 13,335 | -9.4% | 0.00% | -42.9% |
| Q2 2019 | $3,708,115,000 | +4.2% | 14,720 | -1.0% | 0.01% | -12.5% |
| Q1 2019 | $3,558,837,000 | -18.4% | 14,870 | -21.7% | 0.01% | -20.0% |
| Q4 2018 | $4,359,755,000 | -23.9% | 18,986 | -6.2% | 0.01% | +25.0% |
| Q3 2018 | $5,725,970,000 | +0.2% | 20,251 | +4.0% | 0.01% | -20.0% |
| Q2 2018 | $5,715,897,000 | -11.1% | 19,465 | -23.6% | 0.01% | -16.7% |
| Q1 2018 | $6,428,123,000 | +2.0% | 25,468 | -12.7% | 0.01% | +9.1% |
| Q4 2017 | $6,302,664,000 | +328.9% | 29,179 | +269.0% | 0.01% | +175.0% |
| Q3 2017 | $1,469,516,000 | +67.1% | 7,907 | +55.1% | 0.00% | +33.3% |
| Q2 2017 | $879,405,000 | +91.3% | 5,098 | +69.3% | 0.00% | +200.0% |
| Q1 2017 | $459,780,000 | -4.7% | 3,011 | -8.1% | 0.00% | -50.0% |
| Q4 2016 | $482,571,000 | +71.8% | 3,275 | +47.4% | 0.00% | +100.0% |
| Q3 2016 | $280,816,000 | -45.0% | 2,222 | -50.9% | 0.00% | -50.0% |
| Q2 2016 | $510,532,000 | +125.7% | 4,528 | +108.4% | 0.00% | +100.0% |
| Q1 2016 | $226,209,000 | -26.6% | 2,173 | -20.5% | 0.00% | 0.0% |
| Q4 2015 | $308,340,000 | -4.9% | 2,734 | -7.7% | 0.00% | 0.0% |
| Q3 2015 | $324,230,000 | +148.5% | 2,961 | +117.1% | 0.00% | – |
| Q2 2015 | $130,480,000 | -63.6% | 1,364 | -64.6% | 0.00% | -100.0% |
| Q1 2015 | $358,682,000 | -5.0% | 3,851 | -16.5% | 0.00% | 0.0% |
| Q4 2014 | $377,723,000 | +556.1% | 4,612 | +414.2% | 0.00% | – |
| Q3 2014 | $57,569,000 | +4634.3% | 897 | +4385.0% | 0.00% | – |
| Q2 2014 | $1,216,000 | -88.6% | 20 | -88.0% | 0.00% | – |
| Q4 2013 | $10,640,000 | -95.5% | 167 | -95.2% | 0.00% | – |
| Q3 2013 | $238,231,000 | -39.8% | 3,507 | -36.1% | 0.00% | – |
| Q2 2013 | $395,465,000 | – | 5,488 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |